HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.

AbstractBACKGROUND:
Cancer stem cells (CSCs) play an important role in cancer initiation, relapse and metastasis. To date, no specific medicine has been found to target CSCs as they are resistant to most conventional therapies and proliferate indefinitely. Compound Kushen Injection (CKI) has been widely used for cancer patients with remarkable therapeutic effects in Chinese clinical settings for many years. This study focused on whether CKI could inhibit MCF-7 SP cells in vitro and in vivo.
METHODS:
The analysis of CKI on SP population and the main genes of Wnt signaling pathway were studied first. Then we studied the tumorigenicity of SP cells and the effects of CKI on SP cells in vivo. The mice inoculated with 10,000 SP cells were randomly divided into three groups (6 in each group) and treated with CKI, cisplatin and saline (as a control) respectively for 7 weeks. The tumor formation rates of each group were compared. The main genes and proteins of the Wnt signaling pathway were analyzed by RT-PCR and western blot.
RESULTS:
CKI suppressed the size of SP population (approximately 90%), and down-regulated the main genes of Wnt signaling pathway. We also determined that MCF-7 SP cells were more tumorigenic than non-SP and unsorted cells. The Wnt signaling pathway was up-regulated in tumors derived from SP cells compared with that in tumors from non-SP cells. The tumor formation rate of the CKI Group was 33% (2/6, P < 0.05), and that of Cisplatin Group was 50%(3/6, P < 0.05), whereas that of the Control Group was 100% (6/6).The RT-PCR and western blot results indicated that CKI suppressed tumor growth by down-regulating the Wnt/β-catenin pathway, while cisplatin activated the Wnt/β-catenin pathway and might spare SP cells.
CONCLUSIONS:
It suggested that CKI may serve as a novel drug targeting cancer stem-like cells, though further studies are recommended.
AuthorsWeiru Xu, Hongsheng Lin, Ying Zhang, Xinyi Chen, Baojin Hua, Wei Hou, Xin Qi, Yingxia Pei, Xiaoyun Zhu, Zhizheng Zhao, Liangliang Yang
JournalJournal of experimental & clinical cancer research : CR (J Exp Clin Cancer Res) Vol. 30 Pg. 103 (Oct 28 2011) ISSN: 1756-9966 [Electronic] England
PMID22032476 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drugs, Chinese Herbal
  • RNA, Messenger
  • Wnt Proteins
  • beta Catenin
  • kushen
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, chemistry, pharmacology)
  • Cell Line, Tumor
  • Down-Regulation (drug effects)
  • Drugs, Chinese Herbal (administration & dosage, chemistry, pharmacology)
  • Female
  • Humans
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Neoplastic Stem Cells (drug effects, metabolism)
  • RNA, Messenger (metabolism)
  • Wnt Proteins (metabolism)
  • Wnt Signaling Pathway (drug effects)
  • Xenograft Model Antitumor Assays
  • beta Catenin (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: